Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | LSS | P48449 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9210680 | 1.00 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1KDM4EPKM | |
| SCHEMBL6053256 | 1.00 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1KDM4EPKM | |
| SCHEMBL28637977 | 1.00 | EPHX1 (0.39) | EPHX1CYP1A2ALDH1A1KDM4EPKM | |
| SCHEMBL1524898 | 0.98 | CYP1A2 (0.40) | EPHX1CYP1A2ALDH1A1KDM4EPKM | |
| SCHEMBL1524848 | 0.92 | CYP1A2 (0.46) | CYP1A2ALDH1A1KDM4EPKMCYP2D6 | |
| SCHEMBL11075927 | 0.89 | MAPK1 (0.37) | ALDH1A1KDM4EPKMTDP1MEN1 | |
| SCHEMBL2138060 | 0.89 | MAPK1 (0.37) | ALDH1A1KDM4EPKMTDP1MEN1 | |
| SCHEMBL2136195 | 0.87 | MAPK1 (0.38) | CYP1A2ALDH1A1KDM4EPKMCYP2D6 | |
| SCHEMBL25269130 | 0.83 | EPHX1 (0.42) | EPHX1CYP1A2ALDH1A1PKMLSS | |
| SCHEMBL6718471 | 0.83 | EPHX1 (0.42) | EPHX1CYP1A2ALDH1A1PKMLSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612123-B2 | Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof | TOAGOSEI CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| EP-1798251-B1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR BRANCHED LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO LTD (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | TOAGOSEI CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1798251-A1 | CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR LONG-CHAIN ALKYL GROUP AND USE THEREOF | TOAGOSEI CO., LTD. (JP) | 2007-06-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108725-A1 | Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof | RAD51, HEATR1, DCXR | EPHX1 492/4885CYP1A2 331/4885ALDH1A1 740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.